AzTrials
AzTrials

MalnutritionPhase 4NCT01432769

Enteral Nutrition After Cardiovascular Surgery

A Phase 4 study testing dietary supplement high in energy and protein in people with Malnutrition and Heart Disease, run by Instituto Mexicano del Seguro Social at 1 site in Mexico.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Effect of enteral nutrition in the outcome of patients has the objective to determine the effect of implementing a nutritional support protocol on the outcome of cardiovascular surgery patients, the main justification of the study its the prevalence of malnutrition over the hospitalized patients and the way this… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Malnutrition, Heart Disease
What is being tested?
dietary supplement high in energy and protein
Could I receive a placebo?
No, everyone receives an active treatment
How many people
38 participants
Where
1 siteMexico
Study dates
Jan 2011to Mar 2012
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients undergoing cardiac surgery for revascularization, valve implant.
  • Patients with some degree of malnutrition or at risk of malnutrition according to the implementation of the Nutritional Risk Screening-2002.
  • By letter of informed consent.

Who cannot join

  • Patients with cancer diagnosis, liver disease, kidney disease.
  • Patients who decide to come out the study
  • Patients who are transferred to other hospitals
  • Patients with complications that prevent them from receiving enteral nutritional.

Trial locations and contacts

1 site in 1 country.

sergio e solorio meza, Doctor contact

7183039

soloriosergio@aol.com

krisein a martínez fuentes, Nutritionist contact

0444772204663

kriseina@hotmail.com

Mexico1 site, 1 recruiting
  • Mexican Institute of social security: highly specialized medical unit number 1 Bajio

    León, Guanajuato

    sergio e solorio meza, doctor, 7183039, sergiosolorio@aol.com

    krisein a martinez fuentes, nutritionist, 0444772204663, kriseina@hotmail.com

    Recruiting

Other trials in Mexico

About this study

Official title: Effect of Enteral Nutrition in the Outcome of Patients With Cardiovascular Surgery

Effect of enteral nutrition in the outcome of patients has the objective to determine the effect of implementing a nutritional support protocol on the outcome of cardiovascular surgery patients, the main justification of the study its the prevalence of malnutrition over the hospitalized patients and the way this complication influence the treatment efficacy, the risk of complications over these patients, the costs, the prognosis, mortality and hospital stay.

This study will be a control clinical trial, randomized and double blind.

Read the detailed description

INTRODUCTION: Malnutrition is a complication that occurs frequently in hospitalized patients and influencing treatment efficacy, risks of complications, costs, prognosis, mortality and hospital stay. Cardiac Cachexia is a complication that is characterized by weight loss and suggests different mechanisms to explain it: poor diet, intestinal malabsorption, impaired metabolism, loss of nutrients through the digestive tract or urinary tract, increased protein loss and decreased anabolism, increased basal metabolic rate. It is reported a reduction in mortality in cardiac patients with higher body mass index (BMI), this potential protective effect is known as the obesity paradox. In a clinical study to determine whether BMI influences the risk of mortality in acute decompensated heart failure, the authors compared the BMI of 108 927 hospitalized patients and noted that hospital mortality was decreased as BMI increased, decreasing the risk of death 10% for every 5 unit increase in BMI of patients. Moreover, the enteral nutrition within the first 48hr after surgery, helps maintain the integrity of the intestinal mucosa and reduces the secretion of catabolic hormones. A meta-analysis shows that 85% of high-risk surgical patients tolerate enteral nutrition in the early postoperative period. As a nutritional support in critically ill patients, enteral keeps physiological mechanisms, a lower incidence of complications and low cost. Nutritional support in critically ill patients has three objectives: to conserve body mass, modulate immune function and metabolic response to moderate stress.

OBJECTIVE OF THE STUDY: To determine the effect of implementing a nutritional support protocol on the outcome of cardiovascular surgery patients.

METHODOLOGY: The investigators performed a controlled clinical trial in adult patients, both genders admitted to the coronary intensive care UMAE. IMSS No.1, having undergone cardiac surgery with or without pump. There will be a nutritional screening and patients with malnutrition are included at random to group A (which will immunomodulatory individualized diet) or group B (conventional nutritional treatment). The protocol will be given nutritional support enterally during their hospital stay. The progress of nutritional status will be measured by weight, BMI, albumin, transferrin, total count of lymphocytes and total proteins in addition to the hospital stay, complications and mortality. A comparison of the effect of individualized nutritional support with a standard control group will be performed.

ANALYSIS: The results will be emptied in a database in Excel. The investigators will use statistical packages: NCSS 2007 (01/07/1919) and SPSS (15.0). Qualitative variables will be expressed as percentages, quantitative variables as mean and standard deviation if the distribution is normal. The results will be analyzed according to intention to treat. Comparison of nutritional status by various quantitative indicators will be made by paired t test or Mann Whitney according to their distribution. Categorical variables were expressed as proportions and compared using Chi Square test. All tests will be considered significant p values less than 5%.

Being tested
dietary supplement high in energy and protein
Keywords
enteral nutrition, malnutrition, cardiac surgery
Medical subject headings
Malnutrition, Heart Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • dietary supplement high in energy and proteinDietary supplement

    Also called Brand name: Supportan by Fresenius Kabi

    patients in the "standardized diet" will receive extra 500 kcal from the dietary supplement

Study groups in NCT01432769
Study groupRoleWhat they receive
individualized dietActive comparatorpatients will receive a diet individualized to their calorie and protein requirements besides to dietary supplementation with a polymeric formula
Receives: Dietary Supplement: dietary supplement high in energy and protein
standardized dietNo interventionpatients in the "standardized diet" will receive the dietary management established by the hospital

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. nutritional status

    Will be monitoring anthropometric indicators of nutritional status: weight and BMI, during hospitalization and weekly basis. Will be monitoring the biochemical indicators of nutritional status, albumin, transferrin, total lymphocyte count and total protein during hospitalization and weekly basis.

    Will be monitoring dietary indicators of nutritional status, daily protein intake and total calories during the hospitalization and daily newspaper.

    Measured: 15 days

Secondary outcomes (3)
  1. Days of hospitalization

    To measure the clinical course of patients will be reported the numbers of days of hospitalization of patients

    Measured: 15 days

  2. Infectious complications

    as a secondary objective of the research it will be a recorded the number of patients with infectious complications during hospitalization

    Measured: 15 days

  3. Mortality

    as a secondary objective of the research it will be a recorded the all cause mortality

    Measured: 15 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Sep 2011 (estimated)
  2. Study startJan 2011
  3. Primary completionFeb 2012 (estimated)
  4. Study completionMar 2012 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
38 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01432769
Sponsor's protocol ID
2010-1001-24
Status last verified
Sep 2011
First submitted
7 Sep 2011
Last updated
13 Sep 2011
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing dietary supplement high in energy and protein in people with Malnutrition and Heart Disease, run by Instituto Mexicano del Seguro Social at 1 site in Mexico.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Sep 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Mexico. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact sergio e solorio meza, Doctor (7183039, soloriosergio@aol.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

nutritional status (time frame: 15 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Sep 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in